Indiana continues to lead U.S. in pharmacy robberies
There were more pharmacy robberies in Indiana last year than California, which has a population about six times larger.
Pharmaceutical
Articles
Incoming Lilly CEO pick to focus globally
Dave Ricks will begin guiding the company during a period of relative calm compared with the trying times John Lechleiter navigated during his eight years at the helm.
Lilly CEO Lechleiter to retire at end of year
John Lechleiter has been the company’s CEO since 2008. The announcement Wednesday morning of his retirement comes one day after the firm announced strong revenue and profit for its second quarter, indicating that Lechleiter’s initiatives have paid off.
Anthem, Express Scripts dispute comes down to pricing
The agreement by Indianapolis-based Anthem Inc. to sell its pharmacy-benefits arm to St. Louis-based Express Scripts for $4.7 billion has turned the companies at each other’s throats, culminating in a multibillion-dollar legal battle that began early this year.
Next president should attack drug prices, Obama says in medical journal
President Barack Obama has written a game plan on health care for the next president, including a crackdown on prescription drug prices that may cut pharmaceutical manufacturers’ profits if adopted.
Lilly stock rises after FDA panel backs new Jardiance label
A hot-selling drug for diabetes sold by Eli Lilly and Co. and a co-partner just got another potential boost, as a government panel narrowly recommended that the companies should be allowed to claim that the drug cuts the risk of cardiovascular death.
CEO Ellis resigns after 20 years at struggling drug firm Endocyte
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
Biochemist Richard DiMarchi is ‘true entrepreneur’
Biochemist has founded or co-founded five startups since retiring from Eli Lilly and Co. as head of biotechnology research 13 years ago, at age 50.
HOOSIER BEACON: The legacy of Alec Clowes
Upon his arrival in Indianapolis, Clowes began aggressively pursuing research that might lead to mass-produced pharmaceuticals.
Medicare plan on payment for cancer drugs stirs battle
A Medicare proposal to test new ways of paying for chemotherapy and other drugs given in a doctor's office has sparked a furious battle, and cancer doctors are demanding that the Obama administration scrap the experiment.
Insulin’s surging price turns diabetes staple into luxury good
The three drugmakers that dominate the world diabetes market—Eli Lilly and Co., Novo Nordisk A/S and Sanofi—are introducing improved forms of insulin, with a price tag to match.
Allergan, Pfizer call off proposed record $160B merger
The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland—on paper—to reduce its tax bill.
Meth law opens door for fledgling drugmaker
A small manufacturer angling to pick up more business in Indiana makes cold and allergy medicine resistant to being abused by methamphetamine makers.
Lilly angles for arthritis blockbuster
Within six months, Eli Lilly and Co. could know whether the Food and Drug Administration has approved its latest drug, baricitinib, a once-a-day tablet for treating rheumatoid arthritis.
Lilly wins FDA approval for plaque psoriasis drug
For Eli Lilly and Co., the approval rewards a decade-long effort to re-enter the biotech and autoimmune spaces that it helped pioneer in the 1980s but then abandoned in the 1990s.
Express Scripts leader wants Anthem to stay client despite $15B suit
Express Scripts Holding Co.’s incoming CEO is trying to keep its biggest customer after Anthem Inc. sued to recoup billions of dollars in what it called excess payments for drugs and threatened to end their relationship.
Pence signs anti-methamphetamine proposals into law
Pharmacists in Indiana will be able to limit how much cold medicine customers can buy under a measure Indiana Gov. Mike Pence signed into law Monday.
Anthem slaps lawsuit on Express Scripts over drug pricing
The insurer’s CEO said in January that Anthem should be reaping an addition $3 billion per year in savings on drugs from Express Scripts, which manages its pharmacy benefits.
Indiana House passes two bills to curb meth
Two measures aimed at to reducing methamphetamine production in Indiana are on their way to the governor's desk after receiving approval from the full House.
For Lilly’s Cialis, glory days are over
The erectile-dysfunction drug, made famous by a slew of quirky commercials, is facing performance issues of its own.